Blood-Based Biomarkers: Changing the Landscape of Disease Detection and Management Blood-based biomarkers have the potential to revolutionize how diseases are detected, monitored and treated. Biomarkers are biological molecules found in blood,…
Tag: Cell Free DNA
Genomic Biomarker Market is Expected to be Flourished by Growing Demand for Personalized Medicines
The global genomic biomarker Market is estimated to be valued at US$ 5271.63 Mn in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.